| abstract |
(57) [Summary] [Structure] Recombinant mite allergen having allergen activity obtained by expression of a mite body-derived gene, a gene encoding the mite allergen, mite allergen fragment as an active fragment having allergen activity, and mite Peptide having an epitope contained in allergen, expression vector capable of expressing the gene of the present invention, transformant transformed with the expression vector, method for producing the recombinant mite allergen, and mite allergic disease containing these as active ingredients A therapeutic agent and a diagnostic agent for mite allergic disease are provided. [Effect] According to the present invention, a therapeutic agent for mite allergic disease, It has become possible to provide a safe and effective recombinant mite allergen containing no anaphylaxis-inducing impurities as a diagnostic agent. |